Kim is changing the paradigm of cancer care through genomic-based diagnostic tests for breast, colon and prostate cancers that address the overtreatment and optimal treatment of early-stage cancer.
Prior to Genomic Health, Kim was the SVP of Marketing and Sales at Genentech where she successfully commercialized 14 new therapies over her 15 year tenure.
Kim has been recognized in the biotechnology industry several times for her contributions:
- Most Admired CEO in 2014
- Most Influential Women in the Bay Area from 2006-2012 by the San Francisco Business Times
- Women of the Year in 2008 by Women Health Care Executives
Watch the video below to learn more about how Genomic Health is individualizing cancer care with their genomic tests.
Here’s the video of the interview: